ESC 365 - Why now? mechanistically comparing factor XI inhibitors with NOACs

EHRA Premium Access

Why now? mechanistically comparing factor XI inhibitors with NOACs

Session: Are we seeing a paradigm shift in anticoagulation? NOACs and factor XIa inhibitors

Topic: European Heart Rhythm Association (EHRA)

Speaker: Professor V. Roldan-Schilling (Murcia, ES)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Professor Vanessa Roldan-Schilling

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

3 presentations

1 follower

3 more presentations in this session

Where we are now? balancing stroke and bleeding in atrial fibrillation

Speaker: Professor G. Lip (Liverpool, GB)

Where are we heading? factor XI inhibitors for atrial fibrillation and stroke prevention

Speaker: Professor J. Deharo (Marseille, FR)

What about holistic or integrated care management for atrial fibrillation?

Speaker: Associate Professor M. Proietti (Milan, IT)

Access the full session

Are we seeing a paradigm shift in anticoagulation? NOACs and factor XIa inhibitors

Speakers: Professor V. Roldan-Schilling, Professor G. Lip, Professor J. Deharo, Associate Professor M. Proietti

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources